Dr. Baruch D. Kuppermann, MD

Dr. Kuppermann practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Kuppermann's NPI, 1326128455, was assigned on October 16, 2006. Dr. Kuppermann graduated from University of Miami, Miller School of Medicine in 1985. Dr. Kuppermann's California license number on file is G63254.

Dr. Kuppermann's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Kuppermann's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dmand AI also links Dr. Kuppermann to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuppermann practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Kuppermann's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Kuppermann is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kuppermann's licenses on file in 3 states: California, Florida and Maryland.

Dmand AI lists age-related macular degeneration, cataract, dry eye, glaucoma, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Kuppermann treats.

CMS data shows 3,123 Medicare services from Dr. Kuppermann across 5 procedure codes in 2024, for 390 Medicare patients. Medicare paid $133,285 for them. Every service was in an office.

CMS counts 390 Medicare patients who saw Dr. Kuppermann in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kuppermann's median patient age at 79, with 57% women.

In 2024, Dr. Kuppermann wrote 37 Medicare Part D claims for 15 patients. 81% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $593 in total drug cost. In 2022, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kuppermann for performance year 2024, reported through an alternative payment model (APM). Dr. Kuppermann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 177 papers to Dr. Kuppermann, published from 2009 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Visual Acuity, Angiogenesis Inhibitors and Intravitreal Injections. Dr. Kuppermann has published most often in Eye (Lond). Dr. Kuppermann's most frequent co-authors are Anthony Bart Nesburn, MD, Carl D. Regillo, MD and Scott M. Whitcup, MD.

Dmand AI links Dr. Kuppermann to 6 clinical trials. Conditions studied include Retinitis Pigmentosa, Retinal Dystrophies and Cytomegalovirus Retinitis. jCyte, Inc sponsors the most, 2.

CMS Open Payments shows 571 general payments to Dr. Kuppermann from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Allergan Inc. paid the most, $806,691.

Dmand AI lists 8 awards for Dr. Kuppermann, most recently Best Doctors in America in 2019.

Dr. Kuppermann graduated from University of Miami, Miller School of Medicine in 1985. Dr. Kuppermann is a member of AAO.

Dr. Kuppermann is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.